The offering closes the capital raise, but the company's cash runway remains short. Monitor for further dilution if the warrant reset provision triggers (stock below $8.99) or if additional capital is needed. The conflict of interest with MDB Capital and the going-concern warning suggest high risk of further distressed financing.
Price Chart
Executive Summary
EXOZYMES INC. closed its underwritten public offering of common stock and warrants, including partial exercise of the over-allotment option, raising approximately $5.95 million in gross proceeds. The offering is highly dilutive (over 660,000 shares issued vs. a ~$63M market cap) and the company faces a going-concern risk with only $1.44M cash as of March 31, 2026. This filing confirms the capital raise previously announced on June 8, 2026, and does not change the bearish outlook.
Key Facts
- Gross proceeds of approximately $5.95 million from the offering, including over-allotment of 34,440 units (68,880 shares + 34,440 warrants).
- Total shares issued: 661,150 (592,270 initial + 68,880 over-allotment); total warrants: 330,575 (296,135 + 34,440).
- Warrants exercisable at $11.24 per share, one-year lockout, five-year term, with a price reset to $0.001 if the company sells shares below $8.99 before June 5, 2027.
- Underwriter MDB Capital has a conflict of interest as its parent owns 46.1% of EXOZ (per prior filing).
- Company has a going-concern risk, recurring losses, and accumulated deficit of $23.5M as of March 31, 2026.
Financial Impact
Dilution of approximately 10% of shares outstanding; gross proceeds of $5.95M provide limited cash runway given $1.44M cash on hand and $23.5M accumulated deficit.
Risk Factors
- Going-concern risk: company may not have sufficient funds to continue operations beyond the near term.
- Further dilution from warrants (330,575 potential shares) and potential reset to $0.001 if stock trades below $8.99.
- Conflict of interest with underwriter MDB Capital (affiliate of largest shareholder) may not align with minority shareholder interests.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-029119 |
| Exhibit: ex99-1.htm | 0001493152-26-029119 |
| Document: 0001493152-26-029119-index-headers.html | 0001493152-26-029119 |
| Document: 0001493152-26-029119-index.html | 0001493152-26-029119 |
| Document: 0001493152-26-029119.txt | 0001493152-26-029119 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 17d ago | 8-K | $5.25 | awaiting T+20 | — | $3.75 (−28.57%) |
Sep 28, 2026 28d ago | DEFA14A | $6.10 | awaiting T+20 | — | $3.75 (−38.52%) |
Sep 28, 2026 28d ago | DEF 14A | $6.10 | awaiting T+20 | — | $3.75 (−38.52%) |
Sep 18, 2026 5w ago | 8-K | $6.44 $4.09 | ▼ −36.44% | ▼ −36.65% | $3.75 (−41.72%) |
Jun 30, 2026 16w ago | 424B5 | $8.50 $4.40 | ▲ +48.24% | ▲ +46.05% | $3.75 (+55.88%) |
Jun 25, 2026 17w ago | 8-K | $8.03 $4.70 | ▼ −41.47% | ▼ −42.73% | $3.75 (−53.30%) |
Jun 17, 2026 18w ago | 8-K | $7.83 $6.22 | ▲ +20.56% | ▲ +21.09% | $3.75 (+52.11%) |
Jun 8, 2026 20w ago | 8-K | $8.62 $8.14 | ▲ +5.57% | ▲ +7.20% | $3.75 (+56.50%) |
Jun 8, 2026 20w ago | 424B5 | $8.62 $8.14 | ▲ +5.57% | ▲ +7.20% | $3.75 (+56.50%) |
Jun 4, 2026 20w ago | 424B5 | $9.35 $8.48 | ▲ +9.30% | ▲ +7.93% | $3.75 (+59.89%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers